WaPo fronts a seeming non-story: Now that Plan B is available over-the-counter rather than requiring a prescription, its sales are up. Shocking, that. Next they’ll tell me that sales of iPhones are way up over this time last year.
More interesting is the reaction.
“This is exactly what we hoped would happen,” said Susan F. Wood of the George Washington University School of Public Health. As assistant commissioner for women’s health and director of the Office of Women’s Health at the FDA, Wood pushed for the switch. “What we’re seeing is women who needed this product now finally having access to it. For a woman in that position, it can make a real difference in her life.”
I’m not sure whether someone can be said to “need” a product that terminates pregnancies in the early stages but, yes, the availability of products often results in more people using them.
But conservative groups that fought the change say they are disturbed by the surging use.
Right . . .
“This is very concerning,” said Charmaine Yoest of the Family Research Council, which is among several groups suing the FDA to reverse the decision. “We think this is putting women’s health at risk.”
Well, it’s interesting that the FRC thinks that. Are they right? What evidence do they have?
The story doesn’t say.
UPDATE: Charmaine’s husband, Jack, promises answers tonight. Maybe.








